secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2023-05-26T23:59:59+00:00
Accession:  0001193125-23-155477
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve amended equity plan, adding 1M shares and extending to 2033
--------------------------------------------------------------------------------

- Plan amendment increases share reserve by 1,000,000 shares and extends expiration to June 1, 2033.
- Directors elected: Waleed H. Hassanein, James R. Tobin, Edward M. Basile, Thomas J. Gunderson, Edwin M. Kania, Stephanie Lovell, Merilee Raines, David Weill.
- Say-on-pay proposal approved with 22,963,086 votes for, 1,519,849 against.
- Plan amendment approved with 19,996,361 votes for, 4,483,557 against.
- Ratification of PricewaterhouseCoopers as auditor passed with 26,378,751 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523155477/0001193125-23-155477-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312523155477/d498391d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-155477

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer